COEP
Coeptis Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.99
−8.57%Jul 7, 2026, 00:00 UTC
Z Squared Inc. entered into a sales agreement with Roth Capital Partners, LLC to offer and sell up to $300 million of its common stock in an at-the-market offering.
Jun 4, 2026, 00:00 UTC
Z Squared Inc. signed a $50 million committed equity forward purchase agreement on May 29, 2026, for the sale of its common stock in reliance on Section 4(a)(2) of the Securities Act and Regulation D.